<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33419039</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Epigenetic Regulation of ALS and CMT: A Lesson from <i>Drosophila</i> Models.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">491</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22020491</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the third most common neurodegenerative disorder and is sometimes associated with frontotemporal dementia. Charcot-Marie-Tooth disease (CMT) is one of the most commonly inherited peripheral neuropathies causing the slow progression of sensory and distal muscle defects. Of note, the severity and progression of CMT symptoms markedly vary. The phenotypic heterogeneity of ALS and CMT suggests the existence of modifiers that determine disease characteristics. Epigenetic regulation of biological functions via gene expression without alterations in the DNA sequence may be an important factor. The methylation of DNA, noncoding RNA, and post-translational modification of histones are the major epigenetic mechanisms. Currently, <i>Drosophila</i> is emerging as a useful ALS and CMT model. In this review, we summarize recent studies linking ALS and CMT to epigenetic regulation with a strong emphasis on approaches using <i>Drosophila</i> models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Masamitsu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kansai Gakken Laboratory, Kankyo Eisei Yakuhin Co. Ltd., Seika-cho, Kyoto 619-0237, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omori</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asada</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Core-to-Core Program B, Asia-Africa Science Platforms, JP19K06659</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>Advance Insect Research Promotion Center Grant</GrantID><Agency>Kyoto Institute of Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002607" MajorTopicYN="N">Charcot-Marie-Tooth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Charcot&#x2013;Marie&#x2013;Tooth disease</Keyword><Keyword MajorTopicYN="N">Drosophila melanogaster</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">genetic screening</Keyword><Keyword MajorTopicYN="N">histone modification enzyme</Keyword><Keyword MajorTopicYN="N">long noncoding RNA</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>9</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33419039</ArticleId><ArticleId IdType="pmc">PMC7825332</ArticleId><ArticleId IdType="doi">10.3390/ijms22020491</ArticleId><ArticleId IdType="pii">ijms22020491</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J.M., Henry R.G., Langmore S., Kramer J.H., Miller B.L., Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch. Neurol. 2007;64:530&#x2013;534. doi: 10.1001/archneur.64.4.530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.4.530</ArticleId><ArticleId IdType="pubmed">17420314</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M., Takashima H. Drosophila Charcot-Marie-Tooth disease models. Adv. Exp. Med. Biol. 2018;1076:97&#x2013;118. doi: 10.1007/978-981-13-0529-0_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-0529-0_7</ArticleId><ArticleId IdType="pubmed">29951817</ArticleId></ArticleIdList></Reference><Reference><Citation>Saifi G.M., Szigeti K., Snipes G.J., Garcia C.A., Lupski J.R. Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies. J. Investig. Med. 2003;51:261&#x2013;283. doi: 10.1136/jim-51-05-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-51-05-14</ArticleId><ArticleId IdType="pubmed">14577517</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder J.M. Neuropathology of Charcot-Marie-Tooth and related disorders. Neuromol. Med. 2006;8:23&#x2013;42. doi: 10.1385/NMM:8:1-2:23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:8:1-2:23</ArticleId><ArticleId IdType="pubmed">16775365</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisic N., Claeys K.G., Sirotkovic-Skerlev M., Lofgren A., Nelis E., De Jonghe P., Timmerman V. Charcot-Marie-Tooth disease: A clinico-genetic confrontation. Ann. Hum. Genet. 2008;72:416&#x2013;441. doi: 10.1111/j.1469-1809.2007.00412.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-1809.2007.00412.x</ArticleId><ArticleId IdType="pubmed">18215208</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Mizuta I., Tokuda T., Mizuno T. Amyotrophic lateral sclerosis model. Adv. Exp. Med. Biol. 2018;1076:79&#x2013;95. doi: 10.1007/978-981-13-0529-0_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-0529-0_6</ArticleId><ArticleId IdType="pubmed">29951816</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Allis C.D., Jenuwein T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 2016;17:487&#x2013;500. doi: 10.1038/nrg.2016.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2016.59</ArticleId><ArticleId IdType="pubmed">27346641</ArticleId></ArticleIdList></Reference><Reference><Citation>Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010;28:1057&#x2013;1068. doi: 10.1038/nbt.1685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1685</ArticleId><ArticleId IdType="pubmed">20944598</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi I.A., Mehler M.F. Epigenetic mechanisms underlying nervous system disease. Handb. Clin. Neurol. 2018;147:43&#x2013;58. doi: 10.1016/B978-0-444-63233-3.00005-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63233-3.00005-1</ArticleId><ArticleId IdType="pmc">PMC6822391</ArticleId><ArticleId IdType="pubmed">29325627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett A.A., Tanaz R., Cobos S.N., Torrente M.P. Epigenetics in amyotrophic lateral sclerosis: A role for histone post translational modification in neurodegenerative disease. Transl. Res. 2019;204:19&#x2013;30. doi: 10.1016/j.trsl.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandy U.B., Nichols C.D. Human disease models in Drosophila melanogaster and its role of the fly in therapeutic drug discovery. Pharmacol. Rev. 2011;63:411&#x2013;436. doi: 10.1124/pr.110.003293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.110.003293</ArticleId><ArticleId IdType="pmc">PMC3082451</ArticleId><ArticleId IdType="pubmed">21415126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Jaiswal M., Charng W.L., Gambin T., Karaca E., Mirzaa G., Wiszniewski W., Sandoval H., Haelterman N.A., Xiong B., et al. A Drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases. Cell. 2014;159:200&#x2013;214. doi: 10.1016/j.cell.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.002</ArticleId><ArticleId IdType="pmc">PMC4298142</ArticleId><ArticleId IdType="pubmed">25259927</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Sreedharan J. Amyotrophic lateral sclerosis: Recent genetic highlights. Curr. Opin. Neurol. 2016;29:557&#x2013;564. doi: 10.1097/WCO.0000000000000367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000367</ArticleId><ArticleId IdType="pubmed">27538057</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson M.R., Lagow R.D., Xu K., Zhang B., Bonini N.M. A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J. Biol. Chem. 2008;283:24972&#x2013;24981. doi: 10.1074/jbc.M804817200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804817200</ArticleId><ArticleId IdType="pmc">PMC2529125</ArticleId><ArticleId IdType="pubmed">18596033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N.A., Jr., Maltare A., King H., King H., Smith R., Kim J.H., Taylor J.P., Lloyd T.E., Pandey U.B. Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 2011;20:2510&#x2013;2523. doi: 10.1093/hmg/ddr150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai A., Withers J., Koh Y.H., Parry K., Bao H., Zhang B., Budnik V., Pennetta G. hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in human, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol. Genet. 2008;17:266&#x2013;280. doi: 10.1093/hmg/ddm303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm303</ArticleId><ArticleId IdType="pmc">PMC3516386</ArticleId><ArticleId IdType="pubmed">17947296</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V.K., Romano G., D&#x2019;Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583:1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson G.P., Custer S.K., Freibaum B.D., Guinto J.K., Geffel D., Moore J., Tang W., Winton M.J., Neumann M., Trojanowski J.Q., et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutation in VCP/P97. J. Neurosci. 2010;30:7729&#x2013;7739. doi: 10.1523/JNEUROSCI.5894-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5894-09.2010</ArticleId><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantrapirom S., Lo Piccolo L., Yoshida H., Yamaguchi M. A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities. Exp. Cell Res. 2018;362:461&#x2013;471. doi: 10.1016/j.yexcr.2017.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2017.12.010</ArticleId><ArticleId IdType="pubmed">29247619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gronke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura M., Kyotani A., Azuma Y., Yoshida H., Nguyen T.B., Mizuta I., Yoshida T., Mizuno T., Nakagawa M., Tokuda T., et al. Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway. Exp. Cell Res. 2014;326:36&#x2013;45. doi: 10.1016/j.yexcr.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2014.06.004</ArticleId><ArticleId IdType="pubmed">24928275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L., Xie Q., Tibbetts R.S. Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration. Hum. Mol. Genet. 2015;24:757&#x2013;772. doi: 10.1093/hmg/ddu493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu493</ArticleId><ArticleId IdType="pmc">PMC4291250</ArticleId><ArticleId IdType="pubmed">25281658</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Tokuda T., Kushimura Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Iwasaki Y., et al. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp. Cell Res. 2018;371:311&#x2013;321. doi: 10.1016/j.yexcr.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.08.001</ArticleId><ArticleId IdType="pubmed">30092221</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuma C., Saito Y., Umehara T., Kamimura K., Maeda N., Mosca T.J., Miura M., Chihara T. The Strip-Hippo pathway regulates synaptic terminal formation by modulating actin organization at the Drosophila neuromuscular synapses. Cell Rep. 2016;16:2289&#x2013;2297. doi: 10.1016/j.celrep.2016.07.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.07.066</ArticleId><ArticleId IdType="pmc">PMC5023852</ArticleId><ArticleId IdType="pubmed">27545887</ArticleId></ArticleIdList></Reference><Reference><Citation>Altanbyek V., Cha S.J., Kang G.U., Im D.S., Lee S., Kim H.J., Kim K. Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2016;481:259&#x2013;264. doi: 10.1016/j.bbrc.2016.10.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.10.134</ArticleId><ArticleId IdType="pubmed">27810362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Horie Y., Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114:633&#x2013;639. doi: 10.1007/s00401-007-0299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0299-1</ArticleId><ArticleId IdType="pubmed">17929040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareyson D., Saveri P., Pisciotta C. New developments in Charcot-Marie-Tooth neuropathy and related diseases. Curr. Opin. Neurol. 2017;30:471&#x2013;480. doi: 10.1097/WCO.0000000000000474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000474</ArticleId><ArticleId IdType="pubmed">28678038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitani-Morii F., Noto Y. Recent advances in Drosophila models of Charcot-Marie-Tooth disease. Int. J. Mol. Sci. 2020;21:7419. doi: 10.3390/ijms21197419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197419</ArticleId><ArticleId IdType="pmc">PMC7582988</ArticleId><ArticleId IdType="pubmed">33049996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushimura Y., Tokuda T., Azuma Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Yoshida H., et al. Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43. Am. J. Neurodegener. Dis. 2018;7:11&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840287</ArticleId><ArticleId IdType="pubmed">29531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards J.R., Yarychkivska O., Boulard M., Bestor T.H. DNA methylation and DNA methyltransferases. Epigenet. Chromatin. 2017;10:23. doi: 10.1186/s13072-017-0130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-017-0130-8</ArticleId><ArticleId IdType="pmc">PMC5422929</ArticleId><ArticleId IdType="pubmed">28503201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381&#x2013;395. doi: 10.1038/cr.2011.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyn H., Esteller M. DNA methylation profiling in the clinic: Applications and challenges. Nat. Rev. Genet. 2012;13:679&#x2013;692. doi: 10.1038/nrg3270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3270</ArticleId><ArticleId IdType="pubmed">22945394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell I.G., Kong Y.W., Bushell M. How do microRNAs regulate gene expression? Biochem. Soc. Trans. 2008;36:1224. doi: 10.1042/BST0361224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0361224</ArticleId><ArticleId IdType="pubmed">19021530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J. Additional stories of microRNAs. Exp. Biol. Med. 2014;239:1275&#x2013;1279. doi: 10.1177/1535370214544269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370214544269</ArticleId><ArticleId IdType="pubmed">25092828</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi I.A., Mehler M.F. Long non-coding RNAs: Novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics. 2013;10:632&#x2013;646. doi: 10.1007/s13311-013-0199-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0199-0</ArticleId><ArticleId IdType="pmc">PMC3805860</ArticleId><ArticleId IdType="pubmed">23817781</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzio E.A., Soliman K.F.A. Basic concepts of epigenetics. Epigenetics. 2012;7:119&#x2013;130. doi: 10.4161/epi.7.2.18764.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.7.2.18764</ArticleId><ArticleId IdType="pmc">PMC3335905</ArticleId><ArticleId IdType="pubmed">22395460</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia B.A., Shabanowitz J., Hunt D.F. Characterization of histones and their post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 2007;11:66&#x2013;73. doi: 10.1016/j.cbpa.2006.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2006.11.022</ArticleId><ArticleId IdType="pubmed">17157550</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 2000;403:41. doi: 10.1038/47412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/47412</ArticleId><ArticleId IdType="pubmed">10638745</ArticleId></ArticleIdList></Reference><Reference><Citation>Latham J.A., Dent S.Y. Cross-regulation of histone modifications. Nat. Struct. Mol. Biol. 2007;14:1017&#x2013;1024. doi: 10.1038/nsmb1307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1307</ArticleId><ArticleId IdType="pubmed">17984964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zippo A., Serafini R., Rocchigiani M., Pennacchini S., Krepelova A., Oliviero S. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell. 2009;138:1122&#x2013;1136. doi: 10.1016/j.cell.2009.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.07.031</ArticleId><ArticleId IdType="pubmed">19766566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic regulation of motor neuron cell death through DNA methylation. J. Neurosci. 2011;31:16619&#x2013;16636. doi: 10.1523/JNEUROSCI.1639-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1639-11.2011</ArticleId><ArticleId IdType="pmc">PMC3238138</ArticleId><ArticleId IdType="pubmed">22090490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen S., Meletis K., Fu D., Jhaveri S., Jaenish R. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev. Dyn. 2007;236:1663&#x2013;1676. doi: 10.1002/dvdy.21176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.21176</ArticleId><ArticleId IdType="pubmed">17477386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Gertz B., Chestnut B., Martin L.J. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front. Cell. Neurosci. 2013;7:279. doi: 10.3389/fncel.2013.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00279</ArticleId><ArticleId IdType="pmc">PMC3872319</ArticleId><ArticleId IdType="pubmed">24399935</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: A new target of disease mechanisms. Neurotherapeutics. 2013;10:722&#x2013;733. doi: 10.1007/s13311-013-0205-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0205-6</ArticleId><ArticleId IdType="pmc">PMC3805862</ArticleId><ArticleId IdType="pubmed">23900692</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn J.S., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol. Cell. Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Oliv&#xe1;n S., Zaragoza P., Garcia-Redondo A., Osta R. MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:67. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A., Schoonaert L., Lemmens R., Timmers M., Staats K.A., Laird A.S., Peeters E., Philips T., Goris A., Dubois B., et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med. 2012;18:1418&#x2013;1422. doi: 10.1038/nm.2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2901</ArticleId><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Groselj L.D., Zidar J., Rogeli B., Glavac D., Ravnik-Glavac M. Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic ALS patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Grassi M., Salvi E., Borroni B., Palluzzi F., Pepe D., D&#x2019;Avia F., Padovani A., Archetti S., Rainero I., et al. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. Neurobiol. Aging. 2015;36:e13&#x2013;e26. doi: 10.1016/j.neurobiolaging.2015.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.005</ArticleId><ArticleId IdType="pmc">PMC4706156</ArticleId><ArticleId IdType="pubmed">26154020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambuughin N., Goldfarb L.G., Sivtseva T.M., Davydova T.K., Vladimirtsev V.A., Osakovskiy V.L., Danilova A.P., Nikitina R.S., Ylakhova A.N., Diachkovskaya M.P., et al. Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2. BMC Neurol. 2015;15:223. doi: 10.1186/s12883-015-0481-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-015-0481-3</ArticleId><ArticleId IdType="pmc">PMC4628244</ArticleId><ArticleId IdType="pubmed">26517984</ArticleId></ArticleIdList></Reference><Reference><Citation>Capauto D., Colantoni A., Lu L., Santini T., Peruzzi G., Biscarini S., Morlando M., Shneider N.A., Caffarelli E., Laneve P., et al. A regulatory circuitry between Gria2, miR-409, and miR-495 is affected by ALS FUS mutation in ESC-derived motor neurons. Mol. Neurobiol. 2018;55:7635&#x2013;7651. doi: 10.1007/s12035-018-0884-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0884-4</ArticleId><ArticleId IdType="pmc">PMC6132778</ArticleId><ArticleId IdType="pubmed">29430619</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraoka Y., Yamaguchi M. Drosophila models to study long noncoding RNAs related to neurological disorders. In: Jurga S., Barciszewski J., editors. p405-430 in The Chemical Biology of Long Non-coding RNAs. Springer Nature Singapore Pte Ltd.; Singapore: 2018.</Citation></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul J.W., Gitler A.D. Cell Biology. Clogging information flow in ALS. Science. 2014;345:1118&#x2013;1119. doi: 10.1126/science.1259461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1259461</ArticleId><ArticleId IdType="pubmed">25190778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Partridge L., Isaacs A.M. Genetic models of C9orf72: What is toxic? Curr. Opin. Genet. Dev. 2017;44:92&#x2013;101. doi: 10.1016/j.gde.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.01.006</ArticleId><ArticleId IdType="pubmed">28364657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L. Drosophila as a model to gain insight into the role of lncRNAs in neurological disorders. Adv. Exp. Med. Biol. 2018;1076:119&#x2013;146. doi: 10.1007/978-981-13-0529-0_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-0529-0_8</ArticleId><ArticleId IdType="pubmed">29951818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y., Nakagawa S., Hirose T., Okano H.J., Takao M., Shibata S., Suyama S., Kuwako K.I., Imai T., Murayama S., et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA binding proteins in cis to inhibit transcription. Nature. 2008;454:126&#x2013;130. doi: 10.1038/nature06992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06992</ArticleId><ArticleId IdType="pmc">PMC2823488</ArticleId><ArticleId IdType="pubmed">18509338</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson C.L., Lemmens R., Miskiewicz K., Broom W.J., Hansen V.K., van Vught P.W.J., Landers J.E., Sapp P., Van Den Bosh L., Knight J., et al. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum. Mol. Genet. 2009;18:472&#x2013;481. doi: 10.1093/hmg/ddn375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn375</ArticleId><ArticleId IdType="pmc">PMC2638803</ArticleId><ArticleId IdType="pubmed">18996918</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler G.S., Kristjuhan A., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. Elongator is a histone H3 and H4 acetyltransferase important for normal histone acetylation levels in vivo. Proc. Natl. Acad. Sci. USA. 2002;99:3517&#x2013;3522. doi: 10.1073/pnas.022042899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.022042899</ArticleId><ArticleId IdType="pmc">PMC122555</ArticleId><ArticleId IdType="pubmed">11904415</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ruijter A.J.M., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B.P. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 2003;370:737&#x2013;749. doi: 10.1042/bj20021321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20021321</ArticleId><ArticleId IdType="pmc">PMC1223209</ArticleId><ArticleId IdType="pubmed">12429021</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen C., Schmalbach S., Boeselt S., Sarlette A., Dengler R., Petri S. Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2010;69:573&#x2013;581. doi: 10.1097/NEN.0b013e3181ddd404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ddd404</ArticleId><ArticleId IdType="pubmed">20467334</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El Oussini H., Jambeau M., Sun Y., Mersmann S., Wagner M., Dirterle S., Sinniger J., Dirrig-Grosch S., et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Vidaurre O.G., Adula K.P., Kezunovic N., Wentling M., Huntley G.W., Casaccia P. Subcellular distribution of HDAC1 in neurotoxic conditions is dependent on serine phosphorylation. J. Neurosci. 2017;37:7547&#x2013;7559. doi: 10.1523/JNEUROSCI.3000-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3000-16.2017</ArticleId><ArticleId IdType="pmc">PMC5546117</ArticleId><ArticleId IdType="pubmed">28663197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455&#x2013;458. doi: 10.1038/417455a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417455a</ArticleId><ArticleId IdType="pubmed">12024216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Shanware N.P., Bowler M.J., Tibbetts R.S. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 2010;285:34097&#x2013;34105. doi: 10.1074/jbc.M110.154831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.154831</ArticleId><ArticleId IdType="pmc">PMC2962508</ArticleId><ArticleId IdType="pubmed">20720006</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Chen J., Barnett K.R., Yang L., Brumley E., Zhu H. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. J. Biol. Chem. 2013;288:15035&#x2013;15045. doi: 10.1074/jbc.M112.431957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431957</ArticleId><ArticleId IdType="pmc">PMC3663524</ArticleId><ArticleId IdType="pubmed">23580651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanno M., Sakamoto J., Miura T., Shimamoto K., Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 2007;282:6823&#x2013;6832. doi: 10.1074/jbc.M609554200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609554200</ArticleId><ArticleId IdType="pubmed">17197703</ArticleId></ArticleIdList></Reference><Reference><Citation>Michan S., Sinclair D. Sirtuins in mammals: Insights into their biological function. Biochem. J. 2007;404:1&#x2013;13. doi: 10.1042/BJ20070140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20070140</ArticleId><ArticleId IdType="pmc">PMC2753453</ArticleId><ArticleId IdType="pubmed">17447894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang Y., Tang L., Zhang N., Fan D. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1&#x2013;G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci. Lett. 2011;503:250&#x2013;255. doi: 10.1016/j.neulet.2011.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.08.047</ArticleId><ArticleId IdType="pubmed">21896316</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle C., Salvatori I., Gerbino V., Rossi S., Palamiuc L., Rene F., Carri M.T. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: Pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis. 2014;5:e1296. doi: 10.1038/cddis.2014.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.247</ArticleId><ArticleId IdType="pmc">PMC4611720</ArticleId><ArticleId IdType="pubmed">24946089</ArticleId></ArticleIdList></Reference><Reference><Citation>Cant&#xf3; C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009;20:98&#x2013;105. doi: 10.1097/MOL.0b013e328328d0a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOL.0b013e328328d0a4</ArticleId><ArticleId IdType="pmc">PMC3627054</ArticleId><ArticleId IdType="pubmed">19276888</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N., Knippenberg S., Korner S., Rath K.J., Dengler R., Petri S. Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 2012;71:1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo-G&#xf3;mez R., Ram&#xed;rez-Jarqu&#xed;n U.N., Tovar-y-Romo L.B., Tapia R. Histone deacetylases and their role in motor neuron degeneration. Front. Cell. Neurosci. 2013;8:61. doi: 10.3389/fncel.2013.00243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00243</ArticleId><ArticleId IdType="pmc">PMC3852234</ArticleId><ArticleId IdType="pubmed">24367290</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger S.L. The complex language of chromatin regulation during transcription. Nature. 2007;447:407&#x2013;412. doi: 10.1038/nature05915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05915</ArticleId><ArticleId IdType="pubmed">17522673</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett. 2011;585:2024&#x2013;2031. doi: 10.1016/j.febslet.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.11.010</ArticleId><ArticleId IdType="pmc">PMC3409563</ArticleId><ArticleId IdType="pubmed">21074527</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrowsmith C.H., Bountra C., Fish P.V., Lee K., Schapira M. Epigenetic protein families: A new frontier for drug discovery. Nat. Rev. Drug Discov. 2012;11:384&#x2013;400. doi: 10.1038/nrd3674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3674</ArticleId><ArticleId IdType="pubmed">22498752</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimaji K., Tomida S., Yamaguchi M. Regulation of animal behavior by epigenetic regulators. Front. Biosci. 2019;24:1071&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">30844731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: Who, what, and why. Mol. Cell. 2009;33:1&#x2013;13. doi: 10.1016/j.molcel.2008.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.12.013</ArticleId><ArticleId IdType="pmc">PMC3372459</ArticleId><ArticleId IdType="pubmed">19150423</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo A., Yang Y., Macaluso M., Bedford M.T. A gain-of-function mouse model identifies PRMT6 as a NF-&#x3ba;B coactivator. Nucleic Acids Res. 2014;42:8297&#x2013;8309. doi: 10.1093/nar/gku530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku530</ArticleId><ArticleId IdType="pmc">PMC4117762</ArticleId><ArticleId IdType="pubmed">24939901</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Bauer P.O., Prudencio M., Gendron T.F., Stetler C.T., Yan I.K., Pregent L., Daughrity L., Baker M.C., Rademakers R., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun M.H., Ryu H.H., Jun Y.W., Liu T., Li Y., Lim C.S., Lee Y.S., Kaang B.K., Jang D.J., Lee J.A. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress. Sci. Rep. 2017;7:40474. doi: 10.1038/srep40474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40474</ArticleId><ArticleId IdType="pmc">PMC5240339</ArticleId><ArticleId IdType="pubmed">28094300</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M.Y., Frinkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.Y., Berson A., Kennerdell J.R., Sartoris A., Unger T., Porta S., Kim H.J., Smith E.R., Shilatifard A., Van Deerlin V., et al. Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity. Nat. Commun. 2018;9:4406. doi: 10.1038/s41467-018-06543-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06543-0</ArticleId><ArticleId IdType="pmc">PMC6199344</ArticleId><ArticleId IdType="pubmed">30353006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol. Cell. 2010;37:429&#x2013;437. doi: 10.1016/j.molcel.2010.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.01.026</ArticleId><ArticleId IdType="pmc">PMC2872029</ArticleId><ArticleId IdType="pubmed">20159561</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Lin C., Guest E., Garrett A.S., Mohaghegh N., Swanson S., Marshall S., Florens L., Washburn M.P., Shilatifard A. The super elongation complex family of RNA polymerase II elongation factors: Gene target specificity and transcriptional output. Mol. Cell. Biol. 2012;32:2608&#x2013;2617. doi: 10.1128/MCB.00182-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00182-12</ArticleId><ArticleId IdType="pmc">PMC3434493</ArticleId><ArticleId IdType="pubmed">22547686</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D., Jackson J., Saraf A., Swanson S.K., Seidel C., et al. The little elongation complex regulates small nuclear RNA transcription. Mol. Cell. 2011;44:954&#x2013;965. doi: 10.1016/j.molcel.2011.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.12.008</ArticleId><ArticleId IdType="pmc">PMC3249835</ArticleId><ArticleId IdType="pubmed">22195968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D., Smith E.R., Garruss A.S., Mohaghegh N., Varberg J., Lin C., Jackson J., Gao X., Saraf A., Florens L., et al. The little elongation complex functions at initiation and elongation phases of snRNA gene transcription. Mol. Cell. 2013;51:493&#x2013;505. doi: 10.1016/j.molcel.2013.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.07.003</ArticleId><ArticleId IdType="pmc">PMC4104523</ArticleId><ArticleId IdType="pubmed">23932780</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Lin C., Shilatifard A. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell. Biol. 2012;13:543&#x2013;547. doi: 10.1038/nrm3417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3417</ArticleId><ArticleId IdType="pubmed">22895430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Yamaguchi M. RNAi of arcRNA hsr&#x3c9; affects sub-cellular localization of Drosophila FUS to drive neurodiseases. Exp. Neurol. 2017;292:125&#x2013;134. doi: 10.1016/j.expneurol.2017.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.011</ArticleId><ArticleId IdType="pubmed">28342748</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraoka Y., Nakamura A., Tanaka R., Suda K., Azuma Y., Kushimura Y., Lo Piccolo L., Yoshida H., Mizuta I., Tokuda T., et al. Genetic screening of genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs. Exp. Neurol. 2018;310:1&#x2013;13. doi: 10.1016/j.expneurol.2018.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.009</ArticleId><ArticleId IdType="pubmed">30165075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang M., Deng J., Chen X., Ye Y., Zhu L., Liu J., Ye H., Shen Y., Li Y., et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011;2:477&#x2013;486. doi: 10.1007/s13238-011-1065-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1065-7</ArticleId><ArticleId IdType="pmc">PMC3563268</ArticleId><ArticleId IdType="pubmed">21748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Avequin T., Delarue M., Feuillette S., Frebourg T., Campion D., Lecourtois M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol. Aging. 2012;33:e1&#x2013;e15. doi: 10.1016/j.neurobiolaging.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.008</ArticleId><ArticleId IdType="pubmed">22118902</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R., Liu Y., Yang L., Gal J., Zhu H., Jia J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 2012;7:10. doi: 10.1186/1750-1326-7-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pmc">PMC3325858</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ckel S., Summerer A.K., Th&#xf6;mmes C.M., Pan X., Voigt A., Schulz J.B., Rasse T.M., Dormann D., Haass C., Kahle P.J. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila. Neurobiol. Dis. 2015;74:76&#x2013;88. doi: 10.1016/j.nbd.2014.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.11.003</ArticleId><ArticleId IdType="pubmed">25447237</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.R., Godena V.K., Hewitt V.L., Whitworth A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 2016;25:2378&#x2013;2392. doi: 10.1093/hmg/ddw105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw105</ArticleId><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Jantrapirom S., Nagai Y., Yamaguchi M. FUS toxicity is rescued by the modulation of lncRNA hsr&#x3c9; expression in Drosophila melanogaster. Sci. Rep. 2017;7:15660. doi: 10.1038/s41598-017-15944-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15944-y</ArticleId><ArticleId IdType="pmc">PMC5688078</ArticleId><ArticleId IdType="pubmed">29142303</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Poidevin M., Li X., Li Y., Shu L., Nelson D.L., Li H., Hales C.M., Gearing M., Wingo T.S., et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji Wakisaka K., Tanaka R., Hirashima T., Muraoka Y., Azuma Y., Yoshida H., Tokuda T., Asada S., Suda K., Ichiyanagi K., et al. Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. Brain Res. 2019;1708:207&#x2013;219. doi: 10.1016/j.brainres.2018.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.028</ArticleId><ArticleId IdType="pubmed">30578769</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Lu J., Duan J., Su D., Hou X., Li F., Wang X., Huang B. Gcn5- and Elp3-induced histone H3 acetylation regulates hsp70 gene transcription in yeast. Biochem. J. 2008;409:779&#x2013;788. doi: 10.1042/BJ20070578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20070578</ArticleId><ArticleId IdType="pubmed">17910533</ArticleId></ArticleIdList></Reference><Reference><Citation>Batulan Z., Shinder G.A., Minotti S., He B.P., Doroudchi M.M., Nalbantoglu J., Strong M.J., Durham H.D. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 2003;23:5789&#x2013;5798. doi: 10.1523/JNEUROSCI.23-13-05789.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05789.2003</ArticleId><ArticleId IdType="pmc">PMC6741252</ArticleId><ArticleId IdType="pubmed">12843283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa D.J., Robinson M.B., Hayes C.D., Taylor A.R., Prevette D.M., Oppenheim R.W., Caress J., Milligan C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2007;27:13173&#x2013;13180. doi: 10.1523/JNEUROSCI.4057-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4057-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673412</ArticleId><ArticleId IdType="pubmed">18045911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna S., Esposito S., Masala A., Sini P., Nieddu G., Galioto M., Fais M., Iaccarino C., Cestra G., Crosio C. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death Dis. 2020;11:369. doi: 10.1038/s41419-020-2580-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2580-3</ArticleId><ArticleId IdType="pmc">PMC7224392</ArticleId><ArticleId IdType="pubmed">32409664</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagh D.A., Rasse T.M., Asan E., Hofbauer A., Schwenkert I., Durrbeck H., Buchner S., Dabauvalle M.C., Schmidt M., Qin G., et al. Bruchpilot, a protein with homology to ELKS/CAST, is required for structural integrity and function of synaptic active zones in Drosophila. Neuron. 2006;49:833&#x2013;844. doi: 10.1016/j.neuron.2006.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.02.008</ArticleId><ArticleId IdType="pubmed">16543132</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskiewicz K., Jose L.E., Yeshaw W.M., Valadas J.S., Swerts J., Munck S., Feiguin F., Dermaut B., Verstreken P. HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release. Cell Rep. 2014;8:94&#x2013;102. doi: 10.1016/j.celrep.2014.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.05.051</ArticleId><ArticleId IdType="pubmed">24981865</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F.C., Voigt A., Weber S.S., Van den Haute C., Waldenmaier A., Gorner K., Walter M., Anderson M.L., Kern J.V., Rasse T.M., et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 2010;29:209&#x2013;221. doi: 10.1038/emboj.2009.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.324</ArticleId><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida H., Suzusho N., Suyari O., Yoshida H., Ohno K., Hirose F., Itoh M., Yamaguchi M. Genetic screening for modifiers of the DREF pathway in Drosophila melanogaster: Identification and characterization of HP6 as a novel target of DREF. Nucleic Acids Res. 2009;37:1423&#x2013;1437. doi: 10.1093/nar/gkn1068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn1068</ArticleId><ArticleId IdType="pmc">PMC2655671</ArticleId><ArticleId IdType="pubmed">19136464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimaji K., Konishi T., Yoshida H., Kimura H., Yamaguchi M. Genome-wide genetic screen identified the link between dG9a and epidermal growth factor receptor signaling pathway in vivo. Exp. Cell Res. 2016;346:53&#x2013;64. doi: 10.1016/j.yexcr.2016.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2016.06.013</ArticleId><ArticleId IdType="pubmed">27343629</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga J., Korbai S., Neller A., Zsindely N., Bodai L. Hat1 acetylates histone H4 and modulates the transcriptional program in Drosophila embryogenesis. Sci. Rep. 2019;9:17973. doi: 10.1038/s41598-019-54497-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-54497-0</ArticleId><ArticleId IdType="pmc">PMC6884459</ArticleId><ArticleId IdType="pubmed">31784689</ArticleId></ArticleIdList></Reference><Reference><Citation>Boltengagen M., Huang A., Boltengagen A., Trixl L., Lindner H., Kremser L., Offterdinger M., Lusser A. A novel role for the histone acetyltransferase Hat1 in the CENP-A/CID assembly pathway in Drosophila melanogaster. Nucleic Acids Res. 2016;44:2145&#x2013;2159. doi: 10.1093/nar/gkv1235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1235</ArticleId><ArticleId IdType="pmc">PMC4797270</ArticleId><ArticleId IdType="pubmed">26586808</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell K.H., Dixon M., Calvi B.R. The histone acetyltransferases CBP and Chameau integrate developmental and DNA replication programs in Drosophila ovarian follicle cells. Development. 2012;139:3880&#x2013;3890. doi: 10.1242/dev.083576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.083576</ArticleId><ArticleId IdType="pmc">PMC3445312</ArticleId><ArticleId IdType="pubmed">22951641</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto B., Sagnier T., Berenger H., Bohmann D., Pradel J., Graba Y. Chameau HAT and DRpd3 HDAC function as antagonistic cofactors of JNK/AP-1-dependent transcription during Drosophila metamorphosis. Genes Dev. 2006;20:101&#x2013;112. doi: 10.1101/gad.359506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.359506</ArticleId><ArticleId IdType="pmc">PMC1356104</ArticleId><ArticleId IdType="pubmed">16391236</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Hole K., Pimenta-Marques A., Helsens K., Vandekerckhove J., Martinho R.G., Gevaert K., Arnesen T. NatF Contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation. PLoS Genet. 2011;7:e1002169. doi: 10.1371/journal.pgen.1002169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002169</ArticleId><ArticleId IdType="pmc">PMC3131286</ArticleId><ArticleId IdType="pubmed">21750686</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganuma T., Guti&#xe9;rrez J.L., Li B., Florens L., Swanson S.K., Washburn M.P., Abmayr S.M., Workman J.L. ATAC is a double histone acetyltransferase complex that stimulates nucleosome sliding. Nat. Struct. Mol. Biol. 2008;15:364&#x2013;372. doi: 10.1038/nsmb.1397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1397</ArticleId><ArticleId IdType="pubmed">18327268</ArticleId></ArticleIdList></Reference><Reference><Citation>Weake V.M., Dyer J.O., Seidel C., Box A., Swanson S.K., Peak A., Florens L., Washburn M.P., Abmayr S.M., Workman J.L. Post-transcription initiation function of the ubiquitous SAGA complex in tissue-specific gene activation. Genes Dev. 2011;25:1499&#x2013;1509. doi: 10.1101/gad.2046211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.2046211</ArticleId><ArticleId IdType="pmc">PMC3143940</ArticleId><ArticleId IdType="pubmed">21764853</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyagi N., Wassarman D.A. Genes encoding Drosophila melanogaster RNA polymerase II general transcription factors: Diversity in TFIIA and TFIID components contributes to gene-specific transcriptional regulation. J. Cell Biol. 2000;150:F45&#x2013;F49. doi: 10.1083/jcb.150.2.F45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.150.2.F45</ArticleId><ArticleId IdType="pmc">PMC2180226</ArticleId><ArticleId IdType="pubmed">10908585</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthi-Carter R., Taylor D.M., Pallos J., Lambert E., Amore A., Parker A., Moffitt H., Smith D.L., Runne H., Gokce O., et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl. Acad. Sci. USA. 2010;107:7927&#x2013;7932. doi: 10.1073/pnas.1002924107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002924107</ArticleId><ArticleId IdType="pmc">PMC2867924</ArticleId><ArticleId IdType="pubmed">20378838</ArticleId></ArticleIdList></Reference><Reference><Citation>Durdevic Z., Mobin M.B., Hanna K., Lyko F., Schaefer M. The RNA methyltransferase Dnmt2 is required for efficient Dicer-2-dependent siRNA pathway activity in Drosophila. Cell Rep. 2013;4:931&#x2013;937. doi: 10.1016/j.celrep.2013.07.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.07.046</ArticleId><ArticleId IdType="pubmed">24012760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno K., McCabe D., Czermin B., Imhof A., Pirrotta V. ESC, ESCL and their roles in Polycomb Group mechanisms. Mech. Dev. 2008;125:527&#x2013;541. doi: 10.1016/j.mod.2008.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mod.2008.01.002</ArticleId><ArticleId IdType="pubmed">18276122</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanower G.A., Muller M., Blanton J.L., Honti V., Gyurkovics H., Schedl P. Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics. 2005;169:173&#x2013;184. doi: 10.1534/genetics.104.033191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.104.033191</ArticleId><ArticleId IdType="pmc">PMC1448877</ArticleId><ArticleId IdType="pubmed">15371351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallson G., Hollebakken R.E., Li T., Syrzycka M., Kim I., Cotsworth S., Fitzpatrick K.A., Sinclair D.A., Honda B.M. dSet1 is the main H3K4 di- and tri-methyltransferase throughout Drosophila development. Genetics. 2012;190:91&#x2013;100. doi: 10.1534/genetics.111.135863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.111.135863</ArticleId><ArticleId IdType="pmc">PMC3249358</ArticleId><ArticleId IdType="pubmed">22048023</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cai R., Zhou R., Li Y., Liu L. Tousled-like kinase mediated a new type of cell death pathway in Drosophila. Cell Death Differ. 2016;23:146&#x2013;157. doi: 10.1038/cdd.2015.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.77</ArticleId><ArticleId IdType="pmc">PMC4815984</ArticleId><ArticleId IdType="pubmed">26088162</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak&#xe1;ts S., Pircs K., Nagy P., Varga A., K&#xe1;rp&#xe1;ti M., Heged&#x171;s K., Kramer H., Kov&#xe1;cs A.L., Sass M., Juh&#xe1;sz G. Interaction of the HOPS complex with Syntaxin 17 mediates autophagosome clearance in Drosophila. Mol. Biol. Cell. 2014;25:1338&#x2013;1354. doi: 10.1091/mbc.e13-08-0449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e13-08-0449</ArticleId><ArticleId IdType="pmc">PMC3982998</ArticleId><ArticleId IdType="pubmed">24554766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin T., Xuan T., Tan J., Li M., Zhao G., Li M. The Drosophila putative histone acetyltransferase Enok maintains female germline stem cells through regulating Bruno and the niche. Dev. Biol. 2013;384:1&#x2013;12. doi: 10.1016/j.ydbio.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2013.10.001</ArticleId><ArticleId IdType="pubmed">24120347</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalaby N.A., Sayed R., Zhang Q., Scoggin S., Eliazer S., Rothenfluh A., Buszczak M. Systematic discovery of genetic modulation by Jumonji histone demethylases in Drosophila. Sci. Rep. 2017;7:5240. doi: 10.1038/s41598-017-05004-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05004-w</ArticleId><ArticleId IdType="pmc">PMC5507883</ArticleId><ArticleId IdType="pubmed">28701701</ArticleId></ArticleIdList></Reference><Reference><Citation>Seller C.A., Cho C.Y., O&#x2019;Farrell P.H. Rapid embryonic cell cycles defer the establishment of heterochromatin by Eggless/SetDB1 in Drosophila. Genes Dev. 2019;33:403&#x2013;417. doi: 10.1101/gad.321646.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.321646.118</ArticleId><ArticleId IdType="pmc">PMC6446540</ArticleId><ArticleId IdType="pubmed">30808658</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahashi R., Crevel G., Pasko J., Suyari O., Nagai R., Saura M.M., Yamaguchi M., Cotterill S. DNA polymerase &#x3b1; interacts with PrSet7 and mediates H4K20 monomethylation in Drosophila. J. Cell Sci. 2014;127:3066&#x2013;3078. doi: 10.1242/jcs.144501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.144501</ArticleId><ArticleId IdType="pubmed">24806961</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzig B., Yakulov T.A., Klinge K., G&#xfc;nesdogan U., J&#xe4;ckle H., Herzig A. B&#xe4;llchen is required for self-renewal of germline stem cells in Drosophila melanogaster. Biol. Open. 2014;3:510&#x2013;521. doi: 10.1242/bio.20147690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.20147690</ArticleId><ArticleId IdType="pmc">PMC4058086</ArticleId><ArticleId IdType="pubmed">24876388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam S.H., Kanwal S., Nam D.E., Lee M.H., Kang T.H., Jung S.C., Choi B.O., Chung K.W. Association of miR-149 polymorphism with onset age and severity in Charcot-Marie-Tooth disease type 1A. Neuromuscul. Disord. 2018;28:502&#x2013;507. doi: 10.1016/j.nmd.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.04.002</ArticleId><ArticleId IdType="pubmed">29729827</ArticleId></ArticleIdList></Reference><Reference><Citation>Carra S., Crippa V., Rusmini P., Boncoraglio A., Minoia M., Giorgetti E., Kampinga H.H., Poletti A. Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins. Prog. Neurobiol. 2012;97:83&#x2013;100. doi: 10.1016/j.pneurobio.2011.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.09.009</ArticleId><ArticleId IdType="pubmed">21971574</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ydewalle C., Krishnan J., Chiheb D.M., Damme P.V., Irobi J., Kozikowski A.P., Vanden Berghe P., Timmerman V., Robberecht W., Van Den Bosch L. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 2011;17:968&#x2013;974. doi: 10.1038/nm.2396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2396</ArticleId><ArticleId IdType="pubmed">21785432</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonellis A., Ellsworth R.E., Sambuughin N., Puls I., Abel A., Lee-Lin S.Q., Jordanova A., Kremensky I., Christodoulou K., Middleton L.T., et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 2003;72:1293&#x2013;1299. doi: 10.1086/375039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/375039</ArticleId><ArticleId IdType="pmc">PMC1180282</ArticleId><ArticleId IdType="pubmed">12690580</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoy V., Van Helleputte L., Prior R., d&#x2019;Ydewalle C., Haeck W., Geens N., Scheveneels W., Schevenels B., Cader M.Z., Talbot K., et al. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. Brain. 2018;141:673&#x2013;687. doi: 10.1093/brain/awx375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx375</ArticleId><ArticleId IdType="pmc">PMC5837793</ArticleId><ArticleId IdType="pubmed">29415205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A., Shilatifard A., Muir T.W., Roeder R.G. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell. 2009;137:459&#x2013;471. doi: 10.1016/j.cell.2009.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.027</ArticleId><ArticleId IdType="pmc">PMC2678028</ArticleId><ArticleId IdType="pubmed">19410543</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Li L., Zhou B., Qin Z., Dou Y. H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb. Mol. Cell. 2014;54:920&#x2013;931. doi: 10.1016/j.molcel.2014.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.04.013</ArticleId><ArticleId IdType="pmc">PMC4065619</ArticleId><ArticleId IdType="pubmed">24837678</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xfc;st H.M., Wegener A., Fr&#xf6;b F., Hartwig A.C., Wegwitz F., Kari V., Schimmel M., Tamm E.R., Johnsen S.A., Wegner M., et al. Egr2-guided histone H2B monoubiquitination is required for peripheral nervous system myelination. Nucleic Acids Res. 2020;48:8959&#x2013;8976. doi: 10.1093/nar/gkaa606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa606</ArticleId><ArticleId IdType="pmc">PMC7498331</ArticleId><ArticleId IdType="pubmed">32672815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevilla T., Lupo V., Martinez-Rubio D., Sancho P., Sivera R., Chumillas M.J., Garcia-Romero M., Pascual-Pascual A.I., Muelas N., Dopazo J., et al. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Brain. 2016;139:62&#x2013;72. doi: 10.1093/brain/awv311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv311</ArticleId><ArticleId IdType="pubmed">26497905</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchasovnikarova I.A., Timms R.T., Douse C.H., Roberts R.C., Dougan G., Kingston R.E., Modis Y., Lehner P.J. Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2. Nat. Genet. 2017;49:1035&#x2013;1044. doi: 10.1038/ng.3878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3878</ArticleId><ArticleId IdType="pmc">PMC5493197</ArticleId><ArticleId IdType="pubmed">28581500</ArticleId></ArticleIdList></Reference><Reference><Citation>Douse C.H., Bloor S., Liu Y., Shamin M., Tchasovnikarova I.A., Timms R.T., Lehner P.J., Modis Y. Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms. Nat. Commun. 2018;9:651. doi: 10.1038/s41467-018-03045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03045-x</ArticleId><ArticleId IdType="pmc">PMC5811534</ArticleId><ArticleId IdType="pubmed">29440755</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada S., Muraoka Y., Ibaraki K., Takano-Shimizu-Kouno T., Yoshida H., Yamaguchi M. Identification of CR43467 encoding a long non-coding RNA as a novel genetic interactant with dFIG4, a CMT-causing gene. Exp. Cell Res. 2020;386:111711. doi: 10.1016/j.yexcr.2019.111711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.111711</ArticleId><ArticleId IdType="pubmed">31704059</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi Y., Okunushi R., Hara T., Hashiguchi A., Yuan J., Yoshimura A., Murayama K., Ohtake A., Ando M., Hiramatsu Y., et al. Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy. Brain. 2018;141:1622&#x2013;1636. doi: 10.1093/brain/awy104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy104</ArticleId><ArticleId IdType="pmc">PMC5972596</ArticleId><ArticleId IdType="pubmed">29718187</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Suda K., Ueoka I., Tanaka R., Yoshida H., Okada Y., Okamoto Y., Hiramatsu Y., Takashima H., Yamaguchi M. Neuron-specific knockdown of Drosophila HADHB induces a shortened lifespan, deficient locomotive ability, abnormal motor neuron terminal morphology and learning disability. Exp. Cell Res. 2019;379:150&#x2013;158. doi: 10.1016/j.yexcr.2019.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.03.040</ArticleId><ArticleId IdType="pubmed">30953623</ArticleId></ArticleIdList></Reference><Reference><Citation>Dung V.M., Suong D.N.A., Okamaoto Y., Hiramatsu Y., Thao D.T.P., Yoshida H., Takashima H., Yamaguchi M. Neuron-specific knockdown of Drosophila PDHB induces reduction of lifespan, deficient locomotive ability, abnormal morphology of motor neuron terminals and photoreceptor axon targeting. Exp. Cell Res. 2018;366:92&#x2013;102. doi: 10.1016/j.yexcr.2018.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.02.035</ArticleId><ArticleId IdType="pubmed">29501567</ArticleId></ArticleIdList></Reference><Reference><Citation>Janer A., Prudent J., Paupe V., Fahiminiya S., Majewski J., Sgarioto N., Des Rosiers C., Forest A., Lin Z.Y., Gingras A.C., et al. SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome. EMBO Mol. Med. 2016;8:1019&#x2013;1038. doi: 10.15252/emmm.201506159.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201506159</ArticleId><ArticleId IdType="pmc">PMC5009808</ArticleId><ArticleId IdType="pubmed">27390132</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen J., Vashisht A.A., Wan J., Jen J.C., Claypool S.M., Wohlschlegel J.A., Koehler C.M. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria. Mol. Biol. Cell. 2017:600&#x2013;612. doi: 10.1091/mbc.e16-07-0545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e16-07-0545</ArticleId><ArticleId IdType="pmc">PMC5328619</ArticleId><ArticleId IdType="pubmed">28057766</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlesworth G., Balint B., Mencacci N.E., Carr L., Wood N.W., Bhatia K.P. SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy. Mov. Disord. 2016;31:1249&#x2013;1251. doi: 10.1002/mds.26716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26716</ArticleId><ArticleId IdType="pubmed">27430653</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams A.J., Fontanesi F., Tan N.B.L., Buglo E., Campeanu I.J., Rebelo A.P., Kornberg A.J., Phelan D.G., Stark Z., Zuchner S. Insights into the genotype-phenotype correlation and molecular function of SLC25A46. Hum. Mutat. 2018;39:1995&#x2013;2007. doi: 10.1002/humu.23639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23639</ArticleId><ArticleId IdType="pmc">PMC6240357</ArticleId><ArticleId IdType="pubmed">30178502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M.S., Suda K., Kowada R., Ueoka I., Yoshida H., Yamaguchi M. Neuron-specific knockdown of solute carrier protein SLC25A46a induces locomotive defects, an abnormal neuron terminal morphology, learning disability, and shortened lifespan. IBRO Rep. 2020;8:65&#x2013;75. doi: 10.1016/j.ibror.2020.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibror.2020.02.001</ArticleId><ArticleId IdType="pmc">PMC7047145</ArticleId><ArticleId IdType="pubmed">32140609</ArticleId></ArticleIdList></Reference><Reference><Citation>Suda K., Ueoka I., Azuma Y., Muraoka Y., Yoshida H., Yamaguchi M. Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46. Brain Res. 2018;1689:30&#x2013;44. doi: 10.1016/j.brainres.2018.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.028</ArticleId><ArticleId IdType="pubmed">29604258</ArticleId></ArticleIdList></Reference><Reference><Citation>Suda K., Muraoka Y., Ortega-Y&#xe1;&#xf1;ez A., Yoshida H., Kizu F., Hochin T., Kimura H., Yamaguchi M. Reduction of Rpd3 suppresses defects in locomotive ability and neuronal morphology induced by the knockdown of Drosophila SLC25A46 via an epigenetic pathway. Exp. Cell Res. 2019;385:111673. doi: 10.1016/j.yexcr.2019.111673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.111673</ArticleId><ArticleId IdType="pubmed">31614134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima E., Shimaji K., Umegawachi T., Tomida S., Yoshida H., Yoshimoto N., Izawa S., Kimura H., Yamaguchi M. The histone deacetylase gene Rpd3 is required for starvation stress resistance. PLoS ONE. 2016;11:e0167554. doi: 10.1371/journal.pone.0167554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167554</ArticleId><ArticleId IdType="pmc">PMC5132236</ArticleId><ArticleId IdType="pubmed">27907135</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuy An P.N., Shimaji K., Tanaka R., Yoshida H., Kimura H., Fukusaki E., Yamaguchi M. Epigenetic regulation of starvation-induced autophagy in Drosophila by histone methyltransferase G9a. Sci. Rep. 2017;7:7343. doi: 10.1038/s41598-017-07566-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07566-1</ArticleId><ArticleId IdType="pmc">PMC5544687</ArticleId><ArticleId IdType="pubmed">28779125</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimaji K., Tanaka R., Maeda T., Ozaki M., Yoshida H., Ohkawa Y., Sato T., Suyama M., Yamaguchi M. Histone methyltransferase G9a is a key regulator of the starvation-induced behaviors in Drosophila melanogaster. Sci. Rep. 2017;7:14763. doi: 10.1038/s41598-017-15344-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15344-2</ArticleId><ArticleId IdType="pmc">PMC5676964</ArticleId><ArticleId IdType="pubmed">29116191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M., Yoshida H., Takeda K., Okumura T., Taniguchi K., Adachi-Yamada T., Tsuda L., Lim Y.M., Dung V.M., Thao D.T.P., et al. In: Drosophila Models for Human Diseases. Yamaguchi M., editor. Springer Nature Singapore Pte Ltd.; Singapore: 2018.</Citation></Reference><Reference><Citation>Tsuda L., Lim Y.M. Alzheimer&#x2019;s disease model system using drosophila. In: Yamaguchi M., editor. Drosophila Models for Human Diseases. Advances in Experimental Medicine and Biology. Volume 1076. Springer Nature Singapore Pte Ltd.; Singapore: 2018. pp. 25&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">29951813</ArticleId></ArticleIdList></Reference><Reference><Citation>Phokasem P., Jantrapirom S., Karinchai J., Yoshida H., Yamaguchi M., Chantawannakul P. Honeybee products and edible insect powders improve locomotive and learning abilities of Ubiquilin-knockdown Drosophila. BMC Complement. Med. Ther. 2020;20:267. doi: 10.1186/s12906-020-03054-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-020-03054-8</ArticleId><ArticleId IdType="pmc">PMC7457359</ArticleId><ArticleId IdType="pubmed">32867756</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>